Phapros Tbk PT


Phapros Tbk PT

Health CarePharmaceuticals and Biotechnology
  • Price (IDR)710.00
  • Today's Change-40.00 / -5.33%
  • Shares traded223.40k
  • 1 Year change-36.04%
  • Beta0.7828
Data delayed at least 10 minutes, as of Feb 03 2023 08:05 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • PEHA:JKT trading volume exceeds daily average by +64.97%
  • PEHA:JKT price moved over +2.86% to 720.00
  • PEHA:JKT price falls below 50-day moving average to 710.00 at 14:46 GMT
  • PEHA:JKT price rises above 50-day moving average to 740.00 at 13:57 GMT
  • PEHA:JKT price rises above 50-day moving average to 720.00 at 14:03 GMT

Key statistics

On Friday, Phapros Tbk PT (PEHA:JKT) closed at 710.00, 9.23% above its 52-week low of 650.00, set on Jan 13, 2023.
52-week range
650.00Jan 13 20231,145.00Feb 21 2022
Previous close750.00
Average volume74.43k
Shares outstanding840.00m
Free float239.43m
P/E (TTM)36.40
Market cap630.00bn IDR
EPS (TTM)20.61
Annual div (ADY)7.91
Annual div yield (ADY)1.12%
Div ex-dateJun 07 2022
Div pay-dateJun 29 2022
Data delayed at least 10 minutes, as of Feb 03 2023 08:05 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.